Genome-wide transcriptomics identifies an early preclinical signature of prion infection


Sorce S, Nuvolone M, Russo G, Chincisan A, Heinzer D, Avar M, Pfammatter M, Schwarz P, Delic M, Muller M, et al. Genome-wide transcriptomics identifies an early preclinical signature of prion infection. PLoS PathogPLoS PathogPLoS Pathog. 2020;16:e1008653.


The clinical course of prion diseases is accurately predictable despite long latency periods, suggesting that prion pathogenesis is driven by precisely timed molecular events. We constructed a searchable genome-wide atlas of mRNA abundance and splicing alterations during the course of disease in prion-inoculated mice. Prion infection induced PrP-dependent transient changes in mRNA abundance and processing already at eight weeks post inoculation, well ahead of any neuropathological and clinical signs. In contrast, microglia-enriched genes displayed an increase simultaneous with the appearance of clinical signs, whereas neuronal-enriched transcripts remained unchanged until the very terminal stage of disease. This suggests that glial pathophysiology, rather than neuronal demise, could be the final driver of disease. The administration of young plasma attenuated the occurrence of early mRNA abundance alterations and delayed signs in the terminal phase of the disease. The early onset of prion-induced molecular changes might thus point to novel biomarkers and potential interventional targets.


Sorce, SilviaNuvolone, MarioRusso, GiancarloChincisan, AndraHeinzer, DanielAvar, MervePfammatter, ManuelaSchwarz, PetraDelic, MirzetMuller, MichaHornemann, SimoneSanoudou, DespinaScheckel, ClaudiaAguzzi, AdrianoengResearch Support, Non-U.S. Gov't2020/07/01 06:00PLoS Pathog. 2020 Jun 29;16(6):e1008653. doi: 10.1371/journal.ppat.1008653. eCollection 2020 Jun.